CLINICAL_TRIALS
trial_result
· 2011-06-10
Clinical Trial Update: PROCRIT and Short-Term Outcomes in Orthopedic Surgery [Phase 2]
Summary
A Phase 2 trial evaluating PROCRIT (epoetin alfa) for short-term outcomes in orthopedic surgery was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Surgery, Arthroscopy | Phase 2 | Status: TERMINATED